Which activity would not typically be a focus during routine monitoring?

Dispute resolution between the sponsor and investigators is not typically a focus during routine monitoring activities in clinical trials. Routine monitoring is primarily concerned with ensuring compliance with the study protocol, Good Clinical Practice (GCP) guidelines, and regulatory requirements, as well as overseeing the safety of subjects and the integrity of the data collected.

Monitoring activities usually include the review of informed consent processes to ensure that subjects are adequately informed and consenting correctly, verification of data integrity to confirm that the data being reported is accurate and corresponds with what was collected at the clinical site, and assessment of subject safety, as the well-being of participants is the top priority in clinical research. While disputes can occur between sponsors and investigators, they are often handled separately from the routine monitoring process, making dispute resolution less of a focus in these regular monitoring activities.